OrbiMed’s CalciMedica CALC Stock Holding History

OrbiMed’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-297,380	Closed	-$1.24M	–	119
2024 Q1	$1.24M	Hold	297,380	–	–	0.02%	109
2023 Q4	$851K	Hold	297,380	–	–	0.02%	107
2023 Q3	$791K	Hold	297,380	–	–	0.02%	122
2023 Q2	$1.19M	Buy	+297,380	New	+$1.3M	0.02%	119
2023 Q1	–	Sell	-297,382	Closed	-$2.08M	–	129
2022 Q4	$2.08M	Hold	297,382	–	–	0.04%	103
2022 Q3	$3.92M	Hold	297,382	–	–	0.07%	109
2022 Q2	$4.54M	Hold	297,382	–	–	0.08%	114
2022 Q1	$5.12M	Hold	297,382	–	–	0.08%	121
2021 Q4	$7.62M	Hold	297,382	–	–	0.1%	124
2021 Q3	$13.8M	Hold	297,382	–	–	0.15%	113
2021 Q2	$22.6M	Hold	297,382	–	–	0.23%	92
2021 Q1	$23.1M	Sell	297,382 -22,321	-7%	-$6.68M	0.22%	90
2020 Q4	$130M	Hold	319,703	–	–	1.14%	22
2020 Q3	$56.9M	Buy	+319,703	New	+$66.7M	0.72%	40

Other funds holding CALC

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MPM

Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

OrbiMed's CALC Position: Q2 2024 in Review

OrbiMed sold out of CalciMedica (CALC) in Q2 2024, closing a stake of 297,380 shares — an estimated $1.24M sold.

OrbiMed first reported a position in CALC in Q3 2020 and held it in 14 quarters. The position peaked at $130M in Q4 2020. 21 funds tracked by Wall St. Rank hold CALC as of Q2 2024.

OrbiMed reported no remaining CalciMedica position as of Q2 2024 after selling out during the quarter.
OrbiMed sold 297,380 CalciMedica shares in Q2 2024, an estimated $1.24M.
OrbiMed first reported a position in CalciMedica in Q3 2020 and held it in 14 quarters.
OrbiMed's CalciMedica position peaked at $130M in Q4 2020.
21 funds tracked by Wall St. Rank held CalciMedica as of Q2 2024.

Based on OrbiMed's 13F filing for Q2 2024, filed 14 Aug 2024.